Fighting MRSA in hospitals: time to restrict the broad use of specific antimicrobial classes?
Monnet
D L
DL
MacKenzie
F M
FM
Skov
R
R
Jensen
E T
ET
Gould
I M
IM
Frimodt-Møller
N
N
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control* / Q000635:transmission; D004363:Drug Utilization; D024841:Fluoroquinolones / Q000627:therapeutic use; D006291:Health Policy; D006801:Humans; D016106:Methicillin Resistance; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control* / Q000635:transmission; D013211:Staphylococcus aureus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones